Personas / Equipo Humano

Manuel Vázquez Carrera

Buscador de publicaciones

Publicaciones

  • Vilà L, Roglans N, Perna V, Sánchez RM, Vazquez M, Alegret M and Laguna JC.

    Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose.

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY . 22(8): 741-751. Nº de citas: 82

    [doi:10.1016/j.jnutbio.2010.06.005]

  • Serrano-Marco L, Rodríguez-Calvo R, El Kochairi I, Palomer FX, Michalik L, Wahli W and Vazquez M.

    Activation of peroxisome proliferator-activated receptor-ß/-d (PPAR-ß/-d) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

    Diabetes . 60(7): 1990-1999. Nº de citas: 58

    [doi:10.2337/db10-0704]

  • Palomer FX, Álvarez-Guardia D, Davidson MM, Chan TO, Feldman AM and Vazquez M.

    The interplay between NF-kappaB and E2F1 coordinately regulates inflammation and metabolism in human cardiac cells.

    PLoS One . 6(5): . Nº de citas: 29

    [doi:10.1371/journal.pone.0019724]

  • Barroso E, Rodríguez-Calvo R, Serrano-Marco L, Astudillo AM, Balsinde J, Palomer FX and Vazquez M.

    The PPARß/d activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1a-Lipin 1-PPARa pathway leading to increased fatty acid oxidation.

    Endocrinology . 152(5): 1848-1859. Nº de citas: 128

    [doi:10.1210/en.2010-1468]

  • Barroso E, Eyre E, Palomer FX and Vazquez M.

    The peroxisome proliferator-activated receptor ß/d (PPARß/d) agonist GW501516 prevents TNF-a-induced NF-?B activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.

    BIOCHEMICAL PHARMACOLOGY . 81(4): 534-543. Nº de citas: 63

    [doi:10.1016/j.bcp.2010.12.004]

  • Alvarez-Guardia D, Palomer FX, Coll T, Serrano L, Rodríguez-Calvo R, Davidson MM, Merlos M, El Kochairi I, Michalik L, Wahli W and Vazquez M.

    PPARß/d activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1811(2): 59-67. Nº de citas: 65

    [doi:10.1016/j.bbalip.2010.11.002]

  • Alvarez-Guardia D, Palomer FX, Coll T, Davidson MM, Chan TO, Feldman AM, Laguna JC and Vazquez M.

    The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells.

    CARDIOVASCULAR RESEARCH . 87(3): 449-458. Nº de citas: 157

    [doi:10.1093/cvr/cvq080]

  • Coll T, Barroso E, Alvarez-Guardia D, Serrano L, Salvadó L, Merlos M, Palomer FX and Vazquez M.

    The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.

    PPAR Research . 2010: . Nº de citas: 22

    [doi:10.1155/2010/368467]

  • Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer FX, Laguna JC and Vazquez M.

    Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.

    Endocrinology . 151(4): 1560-1569. Nº de citas: 74

    [doi:10.1210/en.2009-1211]

  • Coll T, Palomer FX, Blanco-Vaca F, Escolà-Gil JC, Sánchez RM, Laguna JC and Vazquez M.

    Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells.

    Endocrinology . 151(2): 537-548. Nº de citas: 54

    [doi:10.1210/en.2009-0874]